Peritoneal and Advanced Abdominal Cancer Treatment and Surgery for International Patients in India

What Is Peritoneal Cancer?

The peritoneum is the thin lining covering the abdominal cavity and many abdominal organs. Cancer can seed this surface, producing nodules, plaques, mucin or ascites. Historically this was often considered uniformly terminal; modern treatment recognizes important subgroups in which regional surgery can produce prolonged survival and, in selected patients, durable disease control.

The word "peritoneal" describes where the cancer is, not what it is. A tumour that began in the appendix, the bowel or the ovary and spread to the lining behaves very differently from one that began in the lining itself, and a slow, mucin-producing appendix tumour behaves very differently from an aggressive stomach cancer. This is why the same words, "cancer in the abdomen lining", can lead to a major operation for one person and chemotherapy alone for another.

Which Cancers Are Relevant?

Pancreatic, small-bowel, uterine and some rarer tumours can also spread to the peritoneum. For these, regional surgery is rarely standard, and a specialist team should explain clearly why it is, or is not, being considered.

Why International Patients Consider India

• Access to surgical oncologists experienced in complex abdominal cytoreduction.
• Multispecialty hospitals with colorectal, hepatobiliary, gynecologic, urologic, thoracic and reconstructive backup.
• HIPEC perfusion technology at selected major cancer centres.
• Substantially lower private/self-pay costs than many Western systems.
• Ability to obtain remote multidisciplinary review before travel.
• International-patient departments for visa letters, accommodation and coordination.

Other practical reasons patients look at India include shorter waiting times for specialist review, English widely used in hospitals, the possibility of combining surgery, chemotherapy and follow-up under one roof, and package structures that can be compared item by item. None of this means every patient should travel. India is a sensible option when the diagnosis is established, the imaging is complete, the patient is fit for a long journey and the home team will take over care afterwards. It is not a good option for someone who is obstructed, bleeding, septic or rapidly deteriorating, who needs urgent local treatment first.

How Does India Compare with Other Medical Travel Destinations?

Patients often compare India with Singapore, Turkey, Thailand, South Korea or the Gulf. The honest comparison is about the whole pathway, not the price list:

What Causes Peritoneal Cancer, and Who Is at Higher Risk?

Peritoneal cancer is usually the result of another cancer spreading, so the causes are those of the primary tumour. For many patients no clear cause is found. The factors below raise risk, although many people with risk factors never develop peritoneal disease:

What Are the Symptoms That Lead to Investigation?

Early peritoneal cancer often causes few symptoms, and it is sometimes found on a scan done for another reason or at an operation for another problem. Symptoms that should prompt investigation include:

These symptoms are common to many harmless conditions. They deserve examination and imaging rather than repeated reassurance, especially in anyone with a past bowel, appendix or ovarian cancer.

Imaging, Staging and the Diagnostic Pathway for International Patients in India for Peritoneal and Advanced Abdominal Cancer

Planning aims to answer three questions: what is the exact primary cancer and grade, how much of the abdomen is involved, and could all of it be removed safely? The steps below show how a careful team arrives at the answers:

Each step can change the plan, and skipping one can mean an operation that does not match the real extent of disease. A centre that is willing to explain this sequence for your case is likely to plan carefully.

Who May Be a Candidate for CRS?

• Disease predominantly confined to the peritoneal cavity or with only carefully selected additional sites.
• Tumor biology known to benefit from complete cytoreduction.
• A realistic expectation that all visible disease can be removed without unacceptable loss of bowel or organ function.
• Adequate performance status, nutrition and cardiopulmonary/renal reserve for a prolonged operation.
• No rapidly progressive biology that makes major surgery unlikely to change outcome.

Candidacy is not decided by a single test. It is the combined judgement of the tumour type, the extent of disease on imaging and at exploration, how you responded to any chemotherapy, and whether your body can tolerate a long operation and the recovery that follows.

What Is the Peritoneal Cancer Index (PCI)?

PCI divides the abdomen and pelvis into 13 regions and scores lesion size in each, producing a score from 0 to 39. A higher PCI usually means more extensive disease, but the meaning is cancer-specific: a burden acceptable in low-grade appendiceal PMP may be unsuitable in colorectal cancer.

Why Small-Bowel Disease Matters

Diffuse tumor coating the small bowel or its mesentery can make complete cytoreduction impossible without causing short-bowel syndrome. This is one of the most important reasons a surgeon may appropriately decide not to proceed.

The small bowel is where food is absorbed, and a person needs a certain length of working bowel to maintain nutrition without lifelong intravenous feeding. If tumour is spread throughout the bowel rather than in one or two segments, removing it all would leave too little, so the team may stop or choose chemotherapy rather than cause permanent harm.

When CRS/HIPEC May Not Be Recommended

• Uncontrolled extra-abdominal metastases in most disease settings.
• Diffuse unresectable small-bowel/mesenteric involvement.
• Poor performance status, severe frailty or major organ dysfunction.
• Rapid progression despite appropriate systemic therapy.
• An operation likely to leave substantial macroscopic disease.
• A tumor type in which HIPEC has no established meaningful role.

If a team advises against surgery, ask what they would recommend instead, whether chemotherapy could change the picture and when disease should be reassessed. Being told that an operation is not the right step is a medical judgement, not a rejection.

Records to Send for Remote Review

• Complete pathology report and, if possible, pathology slides/blocks for expert review.
• Recent contrast CT chest/abdomen/pelvis; MRI or PET-CT if performed.
• Actual DICOM imaging, not only written reports.
• Previous operative notes, especially prior bowel/ovarian/appendiceal surgery.
• Chemotherapy drugs, dates, number of cycles and response.
• Tumor-marker trends such as CEA, CA19-9 or CA-125 where relevant.
• Colonoscopy/endoscopy reports where relevant.
• Current blood tests, medications, comorbidities, height/weight and functional status.

Investigations Commonly Used

High-quality CT is the backbone of staging. MRI can better define selected mucinous, pelvic or liver disease. PET-CT is useful selectively but may underestimate low-grade mucinous disease. Diagnostic laparoscopy can directly assess PCI and resectability when imaging is uncertain.

Medical Fitness and Nutrition

Albumin, weight loss, anemia, renal function, diabetes, cardiopulmonary reserve and frailty matter because CRS can last many hours. Prehabilitation and nutritional optimization may be recommended before surgery.

Fitness is assessed with blood tests, an ECG and echocardiogram, lung function tests when relevant, and an anaesthetic review. Many patients begin with weight loss and low protein stores from the disease, so correcting anaemia and rebuilding strength before surgery can lower complications and speed recovery.

Pathology and Molecular Testing for International Patients in India for Peritoneal and Advanced Abdominal Cancer

Treatment depends on the primary tumor and grade. Colorectal disease may require RAS/BRAF and MSI/MMR testing; appendiceal disease must distinguish low-grade mucinous biology from high-grade adenocarcinoma; ovarian pathways may require BRCA/HRD testing.

A second review of your pathology slides by a pathologist who regularly sees peritoneal tumours is often worth doing, because grade and subtype (for example low-grade versus high-grade appendiceal disease) can change the whole plan.

Treatment Options at a Glance

The first treatment depends on the primary cancer, its grade, the extent of disease, how you have responded to any chemotherapy and your wishes. The table summarises how the main pathways compare, and your own team will tailor it:

Is Treatment in India Right for You? A Short Checklist

This checklist is not a decision, but it helps you see whether you are likely to be a good candidate for treatment in India. Ask yourself:

Preparing Before Travel

• Improve protein/calorie intake and correct anemia where possible.
• Stop smoking and optimize diabetes, blood pressure and heart/lung conditions.
• Discuss anticoagulants and all supplements; do not stop medicines independently.
• Build walking strength and respiratory fitness within tolerance.
• Arrange an attendant for a major CRS/HIPEC journey.
• Use flexible flights and plan accommodation close to the hospital.

Preparing yourself before treatment (prehab)

Prehab is not about perfection. Even two or three weeks of better nutrition, daily walking and treatment of anaemia can help, and your team will tell you how much time you can safely spend preparing without delaying treatment.

What Is Cytoreductive Surgery?

CRS removes visible tumor from peritoneal surfaces and involved organs. It is not one operation; it is a tailored combination of peritonectomy and organ resections.

The surgeon works through the abdomen systematically, stripping or removing tumour-bearing lining and any organ that cannot be cleared without removing it. Because the real extent of disease is often only clear once the abdomen is open, the final list of organs removed is decided during surgery, which is why the consent discussion should cover the full range of possibilities.

Procedures That May Be Required

You will not necessarily need all of these. A person with limited low-grade disease may need only a few; extensive disease may need many. Ask your surgeon which are likely for you, and what each would mean for eating, bowel and bladder function afterwards.

Completeness of Cytoreduction

CC-0 means no visible residual disease. CC-1 indicates only tiny residual nodules; CC-2/3 indicate progressively larger macroscopic residual disease. For many indications, the expected ability to achieve CC-0 is one of the strongest reasons to offer surgery.

Multivisceral Surgery

Extensive disease may require several organ resections in one operation. The surgeon must balance cancer clearance against bowel length, urinary/sexual function, nutritional consequences and complication risk.

Possibility of a Stoma

A temporary or permanent ileostomy/colostomy may be required after bowel or rectal resection. Patients should be counselled before surgery rather than learning about this possibility after waking from anesthesia.

What If the Surgeon Finds Unresectable Disease?

A responsible preoperative consent process should discuss this possibility. Depending on findings, the team may take biopsies, relieve obstruction, create a stoma or stop rather than perform a harmful incomplete cytoreduction. Ask in advance what will happen financially and medically if surgery is stopped, who will tell your companion, and how the plan would then change, for example to chemotherapy in India or at home.

Your Surgery Day, Step by Step for International Patients in India for Peritoneal and Advanced Abdominal Cancer

Every hospital has its own routine, but a major CRS operation commonly follows this pattern:

Your companion should know where to wait, how the surgeon will update them, and that long operations are normal. A long time in theatre does not by itself mean something has gone wrong.

What Is HIPEC?

After cytoreduction, heated chemotherapy is circulated through the abdomen for a protocol-defined period. Heat can increase the cytotoxic effect of selected drugs and local delivery exposes microscopic peritoneal disease to high drug concentrations.

The warmed drug is pumped through the abdomen using a perfusion system, commonly at a temperature a few degrees above normal body temperature, for a set time that depends on the drug and protocol. Because much of the drug stays in the abdomen, the whole body is exposed to less than with intravenous chemotherapy, although side effects can still occur.

What HIPEC Cannot Do

Drug penetration is shallow. HIPEC is therefore not a substitute for removing bulky visible tumor.

Common HIPEC Drugs

Mitomycin C, oxaliplatin, cisplatin and other drugs may be used depending on tumor type and institutional protocol. Dose, temperature and duration vary; protocols are not interchangeable.

Colorectal Cancer Nuance

For selected colorectal peritoneal metastases, complete CRS is the critical therapeutic component. Randomized evidence has questioned routine short-duration oxaliplatin HIPEC, so HIPEC should not be marketed as mandatory for every colorectal patient.

Ovarian Cancer Nuance

HIPEC may be considered in selected interval-debulking settings at experienced centres, but it does not replace high-quality cytoreduction or systemic platinum-based treatment.

PIPAC and EPIC

PIPAC (pressurized intraperitoneal aerosol chemotherapy) and EPIC (early postoperative intraperitoneal chemotherapy) are separate techniques. PIPAC is generally used in selected unresectable/research or symptom-control pathways and is not equivalent to CRS/HIPEC.

Intraperitoneal treatments compared

What you may experience after HIPEC

Appendiceal Tumors and Pseudomyxoma Peritonei for International Patients in India for Peritoneal and Advanced Abdominal Cancer

Low-grade appendiceal mucinous disease can behave indolently yet progressively fill the abdomen with mucin. CRS/HIPEC can provide long-term control when complete cytoreduction is feasible. High-grade appendiceal adenocarcinoma behaves more aggressively and may require systemic chemotherapy.

Colorectal Peritoneal Metastases

Selection considers PCI, small-bowel involvement, ability to achieve CC-0, response to systemic therapy, molecular biology and presence of liver/lung disease. Some patients receive chemotherapy before surgery to test biology and improve selection.

Peritoneal Mesothelioma

CRS/HIPEC is an important option for selected patients with resectable malignant peritoneal mesothelioma, but histology, distribution and fitness matter.

Ovarian Cancer

The core surgical principle is maximal cytoreduction to no gross residual disease when safely achievable. Primary surgery versus neoadjuvant chemotherapy followed by interval surgery depends on resectability and fitness.

Gastric and Other Primaries

For most gastric cancers with established peritoneal metastases, systemic therapy remains standard. Regional approaches should be presented as highly selected or investigational unless the patient fits a recognized specialist protocol.

When Chemotherapy Should Come First

Systemic therapy first may be preferable when biology is uncertain, disease burden is high, extra-peritoneal disease is present, or the team wants evidence of disease control before committing to a high-morbidity operation. Starting with chemotherapy is not a delay or a failure. It tests how the cancer behaves, treats unseen disease elsewhere in the body and helps select the patients who will really benefit from a major operation. Ask how response will be measured, and at what point surgery would be reconsidered.

Systemic treatments at a glance

Major Risks of CRS/HIPEC for International Patients in India for Peritoneal and Advanced Abdominal Cancer

• Anastomotic leak, bowel fistula and intra-abdominal abscess.
• Bleeding and transfusion.
• Prolonged ileus and delayed nutrition.
• Sepsis and wound complications.
• Pleural effusion/pneumonia after diaphragm surgery.
• Renal injury, particularly with nephrotoxic perfusion regimens.
• Bone-marrow suppression depending on drug exposure.
• DVT/pulmonary embolism.
• Short-bowel syndrome if excessive intestine is removed.
• Reoperation, prolonged ICU stay and, rarely, treatment-related mortality.

CRS with HIPEC is one of the largest abdominal operations performed. No honest surgeon can quote one risk figure for all patients, because risk depends on the extent of disease, the number of resections, your fitness and whether you have had earlier surgery. Ask the team for its own figures for patients like you.

What Determines Outcome?

Primary tumor biology, grade, PCI, completeness of cytoreduction, response to systemic therapy and patient fitness are more meaningful than the label 'HIPEC' alone.

Previous Abdominal Surgery

Prior operations can create adhesions and distort anatomy, increasing operative time and bowel-injury risk. Previous incomplete debulking can also complicate later definitive CRS.

Older or Medically Complex Patients

Age alone is not an absolute exclusion, but frailty, cardiac/lung/kidney function, nutrition and recovery capacity become increasingly important.

Recurrent Peritoneal Disease

Selected patients may undergo repeat cytoreduction or other local therapy, but recurrence pattern, disease-free interval and feasibility of another complete resection must be reviewed.

What Could Go Wrong, and How Likely Is It?

The table shows how each complication arises and how teams reduce it. Rates differ between centres and patients, so ask the surgeon for the unit's own figures.

Warning Symptoms After Discharge

• Fever or increasing wound redness/drainage.
• Persistent vomiting or abdominal distension.
• New severe abdominal pain.
• Inability to eat/drink or high-output stoma.
• Shortness of breath, chest pain or calf swelling.
• Reduced urine output, dizziness or marked weakness.

Some signs need quick action. Share the table below with your companion, and keep the hospital's emergency number on your phone.

What You Can Do to Reduce Your Risk for International Patients in India for Peritoneal and Advanced Abdominal Cancer

Recovery Timeline

Recovery from CRS with HIPEC is slower and less predictable than from routine abdominal surgery. The table above gives the general pattern, and the table below shows what you and your companion may experience and can do at each stage.

Nutrition After CRS

Small frequent high-protein meals, hydration and dietitian support may be required. Some patients need temporary enteral or parenteral nutrition.

How Long to Stay in India

For uncomplicated major CRS/HIPEC, international patients commonly plan about 3-4 weeks or longer. A leak, abscess, ileus or nutritional problem can extend this substantially.

Fit to Fly and DVT Prevention

Long-haul flight clearance depends on mobility, hydration, wound condition, anemia, bowel function and thromboembolism risk. Continue prescribed anticoagulation exactly as directed and request airport wheelchair assistance if needed.

Accommodation and Attendant

Choose accommodation close to the hospital with lift access, easy bathroom access, suitable food and space for an attendant. After CRS, convenience and rapid access to the treating team are more important than tourism.

Practical Questions Patients Ask After the Operation for International Patients in India for Peritoneal and Advanced Abdominal Cancer

When can I eat normally? Usually in stages. Sips and small meals begin when the bowel starts to work, and normal portions return over weeks. Will I lose weight? Weight loss is common in the first weeks. Small frequent high-protein meals and dietitian support help you regain strength. Will I need a stoma, and will it be permanent? Only if bowel or rectal resection requires it. Many are temporary, and your surgeon should tell you which is likely before surgery. When can I walk and exercise? Walking begins in hospital within a day or two. Gentle daily walking increases over weeks, and heavy lifting waits until your surgeon allows it. When can I drive or work? Often after several weeks to a few months, depending on recovery and the type of work. Your surgeon will advise. When will I know the final pathology? Often within about a week. This report decides whether you need further treatment. Will I need chemotherapy afterwards? Often yes, depending on the cancer and pathology. Your team will agree a plan, ideally before you leave India. Can I have my follow-up care at home? Yes. A home oncologist can manage chemotherapy, scans and blood tests, and your records from India guide the plan. Will the cancer come back? It can. That is why scans, tumour markers and examinations continue for years. Is it safe to be intimate or travel for leisure afterwards? Usually once wounds have healed and your surgeon agrees; ask about timing, a stoma and sexual function in advance.

Travel Practicalities After CRS and HIPEC

Living After Treatment at a Glance

Emotional Wellbeing and Realistic Expectations

A diagnosis of peritoneal cancer is frightening, and the journey to a specialist centre, a long operation and a slow recovery are a great deal to carry. It is normal to feel anxious, tired, angry or low at times. Some people feel guilty or search for a reason why this happened. Peritoneal cancer is not a punishment and nothing you did caused it to spread, so what matters now is the plan ahead, not blame. Ask your team what to expect, and say so if low mood, anxiety or poor sleep continues, because these respond to treatment. Talking to a counsellor, a support group or another patient can ease isolation. Your companion also carries a heavy load and needs rest, food and support.

Special Situations

Choosing a CRS/HIPEC Surgeon

• How many CRS/HIPEC operations does the surgeon/team perform?
• Which primary cancers do they treat most often?
• How do they estimate PCI and decide when not to operate?
• What is their CC-0 rate for patients similar to you?
• What are their major morbidity, reoperation and mortality rates?
• Can they perform complex bowel, diaphragm, liver-surface, pelvic and urinary procedures when required?
• Who manages complications after discharge?

Four more questions to ask

• Will the same surgeon who reviews my records perform the operation, and who will assist?
• Does a multidisciplinary peritoneal tumour board review my case before surgery?
• Can I speak with a previous international patient, or see the ICU and recovery pathway?
• How soon after surgery will I be reviewed by the oncology team about chemotherapy?

Hospital Capabilities

• Dedicated surgical oncology and peritoneal-surface malignancy programme.
• Experienced anesthesiology and ICU/HDU.
• Colorectal, hepatobiliary, gynecologic and urologic backup.
• Interventional radiology and advanced imaging.
• Blood bank and 24-hour emergency surgery.
• Nutrition, stoma care and physiotherapy.
• Medical oncology and molecular pathology.
• International-patient coordination.

What a Good International Patient Service Should Provide

Red Flags for International Patients in India for Peritoneal and Advanced Abdominal Cancer

• HIPEC promised before pathology/imaging review.
• A fixed low package despite unknown PCI and organ resections.
• Claims that HIPEC cures all peritoneal cancers.
• No discussion of incomplete cytoreduction or possibility of aborting surgery.
• No ICU/complication plan.
• Rigid flight-home date after a major CRS operation.

What to Expect: A Realistic Picture of Outcomes

No guide can tell you your own outlook, which only your doctors can estimate from your tumour type, grade, PCI and the completeness of surgery. In general terms:

Use these as orientation only. Ask your own team what your tumour-specific and PCI-specific figures and goals of treatment are, and be wary of any centre that quotes an unusually high success rate without stating the tumour type, PCI and completeness of cytoreduction.

Cost of CRS and HIPEC in India

These are planning ranges only. The final cost depends on what is found and done at surgery, so a firm quotation can only follow review of your own records.

Why Prices Differ

• PCI and operation duration.
• Number of bowel/organ resections.
• HIPEC drug and disposables.
• ICU/HDU duration.
• Blood products and parenteral nutrition.
• Stoma formation.
• Complications or reoperation.
• Room category and hospital tariff.
• Pathology/molecular testing.
• Chemotherapy before/after surgery.

India vs Other Countries

*Broad planning comparisons, not equivalent quotations. Savings are calculated against the India midpoint, and rounded. Systemic drugs, extended ICU care, transplant-level complexity and repeat surgery require separate individualised estimates, and costs in every country vary widely between hospitals.

What the Package Should Clarify

• Surgeon/assistant/anesthesia fees.
• Expected ICU and ward nights.
• HIPEC drug/perfusion/disposables.
• Expected organ resections and stoma supplies.
• Blood products policy.
• Routine pathology and imaging.
• What happens financially if surgery is aborted because disease is unresectable.
• Exclusions for complications, reoperation or extended stay.
• Chemotherapy and post-discharge accommodation.

Budgeting for the Whole Pathway, Not Just the Operation for International Patients in India for Peritoneal and Advanced Abdominal Cancer

The hospital quote is only part of the budget. A realistic plan also includes:

• Return flights for you and a companion, with flexible dates and possibly a changed return date.
• Accommodation and meals for three to four weeks or longer in India, and longer after complications.
• Staging scans, laparoscopy, molecular testing and second-opinion pathology if needed.
• Chemotherapy before or after surgery, usually quoted separately.
• Nutrition supplements, stoma supplies and wound dressings.
• Medical visa fees and travel insurance that covers complications.
• Follow-up scans, tumour markers and consultations at home.
• A contingency for a longer stay, extra ICU days, a repeat procedure or a change of plan at exploration.

Quotation Comparison Table

Use this table to compare written quotations from two hospitals on the same terms:

What Should the Quotation Say About Complications?

• Who pays if a complication such as a leak, abscess or bleeding occurs during the same admission?
• What is charged if the stay is longer than planned, ICU care is extended or a second operation is needed?
• Whether a return to the operating room, drainage procedure or parenteral nutrition is covered, and for how long after surgery.
• What follow-up consultations, scans and pathology review are included before you leave India.
• Whether remote follow-up with the team after you return home is free or charged.

Remote Case Review Before Travel

Send your records first and ask for a written opinion before booking any flight. A good review confirms the primary cancer and grade, estimates the PCI, judges whether complete cytoreduction is realistic, and says whether HIPEC, chemotherapy first or no surgery is the better plan. If the team advises treatment at home, or a different plan, that is useful information, not a lost sale.

Typical Treatment Journey

Medical Visa Planning

International patients should confirm current Indian medical-visa/e-Medical eligibility and attendant rules for their nationality. The hospital can usually provide an invitation/treatment letter after medical review. Visa rules can change and should be checked before travel.

Most patients apply for an e-Medical Visa, and a companion can apply for an e-Medical Attendant Visa. Check the current fees, validity and eligible nationalities on the official Indian e-Visa website before applying. Because CRS/HIPEC recovery is less predictable, ask about visa validity and extension in case your stay is longer than planned.

Documents to Carry Home

• Discharge summary and operative note.
• Final histopathology and molecular results.
• HIPEC drug/protocol details if used.
• Stoma instructions and supplies if applicable.
• Medication/anticoagulation list.
• Nutrition and wound-care plan.
• Written oncology plan for chemotherapy or surveillance.
• Emergency contact details and follow-up schedule.

Your information pack: why each item matters

Arranging Your Follow-Up at Home Before You Leave

Identify a medical oncologist, a surgeon familiar with peritoneal disease or a general surgical oncologist, and if needed a stoma nurse and dietitian at home who are willing to see you, review your records and continue chemotherapy, scans and blood tests. Send them the records before you arrive and agree how they will contact your surgeon in India. This one step does more for safe recovery than almost any other.

Language, Consent and Communication for International Patients in India for Peritoneal and Advanced Abdominal Cancer

• Ask for the consent form and discharge instructions in a language you understand.
• Ask for an interpreter if your English is limited; do not rely on guesses for risks or medicines.
• Make sure the consent explains the range of possible organ resections, the chance of a stoma, the possibility that surgery is stopped, the risk of ICU care and transfusion, and what HIPEC involves.
• Agree who will receive updates, and how, if you cannot answer on the day.
• Save the hospital, surgeon, oncologist and coordinator contact numbers before you travel, and keep your own copies of everything you sign.

Questions to Ask Before Committing

• What is my exact primary cancer and grade?
• What is my estimated PCI?
• Can CC-0 cytoreduction realistically be achieved?
• Why is HIPEC appropriate for my cancer?
• Which organs might need removal?
• What is the chance of a stoma?
• Could chemotherapy first be safer or more informative?
• What happens if unresectable disease is found?
• What are the team's complication and reoperation rates?
• How long should I remain in India?
• Who will look after my chemotherapy and surveillance at home?
• What will it cost if the operation is stopped or complications occur?

Ten FAQs

1. Is HIPEC the same as surgery?

No. CRS is the surgical removal of visible disease; HIPEC is heated intraperitoneal chemotherapy given after cytoreduction in selected settings.

2. Does every peritoneal cancer patient need HIPEC?

No. The indication depends on the primary tumor, biology, PCI and evidence for that disease.

3. What is PCI?

The Peritoneal Cancer Index scores disease size and distribution across 13 abdominal regions from 0 to 39.

4. Can a high PCI still be treated?

Sometimes, particularly in selected appendiceal/PMP disease, but acceptable burden is cancer-specific and small-bowel involvement is crucial.

5. Can CT accurately predict PCI?

Not always. Small implants can be missed, and laparoscopy/laparotomy may reveal more extensive disease.

6. Will I need a stoma?

Possibly if bowel or rectal resection is required. The risk should be discussed before surgery.

7. How long is CRS/HIPEC surgery?

Often many hours; duration depends on PCI and the number of resections required.

8. Can the cancer recur?

Yes. Recurrence risk depends on biology, grade, PCI and completeness of cytoreduction.

9. How long should I stay in India?

Commonly around 3-4 weeks or longer after major CRS/HIPEC, with flexibility for complications.

10. What should I send for an opinion?

Pathology, actual CT/MRI/PET images, operative notes, chemotherapy history, tumor markers, endoscopy reports and current medical information.

11. Is the heated chemotherapy dangerous to the people around me?

No. The drug is circulated inside the abdomen during surgery in a closed system, and staff follow safety protocols; you are not a risk to your companion afterwards.

12. Can I have HIPEC without major surgery?

Heated chemotherapy depends on first removing visible disease. Some less invasive intraperitoneal options such as PIPAC exist, but they are different treatments for selected situations.

13. What if my cancer is found to be unresectable once surgery begins?

The team may take biopsies, relieve obstruction or create a stoma and stop rather than perform an incomplete operation, and the plan then moves to chemotherapy.

14. Will I lose a lot of weight after surgery?

Weight loss is common in the first weeks. Small frequent high-protein meals and dietitian support help most people regain strength over months.

15. Do I need a companion?

Yes, for a major CRS/HIPEC journey. A companion helps with decisions, practical tasks and care, and can apply for an attendant visa.

16. Is a second opinion a good idea?

Yes. Expert pathology review and a second multidisciplinary opinion are reasonable, particularly before a major operation.

Planning Peritoneal Cancer Treatment – Checklist for International Patients in India

Sources

1. 1. Cleveland Clinic - Hyperthermic Intraperitoneal Chemotherapy (HIPEC): https://my.clevelandclinic.org/health/treatments/21569-hyperthermic-intraperitoneal-chemotherapy-hipec
2. 2. Mayo Clinic - Cytoreductive surgery and HIPEC for selected patients with peritoneal carcino matosis: https://www.mayoclinic.org/medical-professionals/cancer/news/cytoreductive-surgery-and-hipec-offers-effective-treatment-for-selected-patients-with-peritoneal-carcinomatosis/mac-20429726
3. 3. Government of India - Indian Visa Online (e-Medical Visa and e-Medical Attendant Visa): https://indianvisaonline.gov.in/evisa/